BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7349950)

  • 1. Comparative receptor-binding properties of heptapeptide and octapeptide antagonists of angiotensin II in rat adrenal glomerulosa and uterine smooth muscle.
    Douglas JG; Michailov M; Khosla MC; Bumpus FM
    Endocrinology; 1980 Jan; 106(1):120-4. PubMed ID: 7349950
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of octa- and heptapeptide antagonists of angiotensin II as inhibitors of angiotensin III binding in the rat adrenal glomerulosa.
    Douglas JG; Khosla MC; Bumpus FM
    Endocrinology; 1985 Apr; 116(4):1598-602. PubMed ID: 3971929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Competitive binding activity of angiotensin II analogues in an adrenal cortex radioligand-receptor assay;
    Saltman S; Baukal A; Waters S; Bumpus FM; Catt KJ
    Endocrinology; 1975 Aug; 97(2):275-82. PubMed ID: 169121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Des-Asp1] angiotensin II: mediator of the renin-angiotensin system?
    Freeman RH; Davis JO; Lohmeier TE; Spielman WS
    Fed Proc; 1977 Apr; 36(5):1766-70. PubMed ID: 321257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the pressor and aldosterone-releasing effects of angiotensin II.
    Bumpus FM; Khosla MC
    Clin Sci Mol Med Suppl; 1975 Jun; 2():15s-18s. PubMed ID: 1077765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two distinct angiotensin II receptor binding sites in rat adrenal revealed by new selective nonpeptide ligands.
    Chang RS; Lotti VJ
    Mol Pharmacol; 1990 Mar; 37(3):347-51. PubMed ID: 2314387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Actions of angiotensin II antagonists upon aldosterone production by isolated adrenal glomerulosa cells.
    Saltman S; Fredlund P; Catt KJ
    Endocrinology; 1976 Apr; 98(4):894-903. PubMed ID: 1278097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptors for angiotensin II and III in rat adrenals.
    Devynck MA; Koreve V; Matthews PG; Meyer P; Pernollet MG
    Adv Nephrol Necker Hosp; 1977; 7():121-135. PubMed ID: 208406
    [No Abstract]   [Full Text] [Related]  

  • 9. Is the adrenal angiotensin receptor angiotensin II--or angiotensin III like?
    Braley LM; Menachery AI; Underwood RH; Williams GH
    Acta Endocrinol (Copenh); 1983 Jan; 102(1):116-21. PubMed ID: 6297210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism and biological activities of angiotensin II and des-Asp1-angiotensin II in isolated adrenal glomerulosa cells.
    Aguilera G; Capponi A; Baukal A; Fujita K; Hauger R; Catt KJ
    Endocrinology; 1979 May; 104(5):1279-85. PubMed ID: 436776
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of octa- and heptapeptide antagonists of angiotensin II as inhibitors of angiotensin II-induced steroidogenesis in the rat adrenal glomerulosa.
    Douglas JG; Michailov M; Khosla MC; Bumpus FM
    Endocrinology; 1981 Jul; 109(1):94-8. PubMed ID: 7238417
    [No Abstract]   [Full Text] [Related]  

  • 12. Specific receptors for des-Asp1-angiotensin II (("angiotensin III") in rat adrenals.
    Devynck MA; Pernollet MG; Matthews PG; Khosla MC; Bumpus FM; Meyer P
    Proc Natl Acad Sci U S A; 1977 Sep; 74(9):4029-32. PubMed ID: 198814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of paired analogs of angiotensin II and angiotensin III on rat smooth muscle.
    Moore GJ; Ko EM
    Pharmacology; 1980; 20(1):36-41. PubMed ID: 7375500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin antagonists and the adrenal cortex and medulla.
    Peach MJ; Ackerly JA
    Fed Proc; 1976 Nov; 35(13):2502-7. PubMed ID: 976492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary biochemical characterization of two angiotensin II receptor subtypes.
    Whitebread S; Mele M; Kamber B; de Gasparo M
    Biochem Biophys Res Commun; 1989 Aug; 163(1):284-91. PubMed ID: 2775266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formation of DES-ASP1-angiotensin II is not an obligatory step in the steroidogenic action of angiotensin II in the canine adrenal.
    Douglas J; Bartley P; Kondo T; Catt K
    Endocrinology; 1978 Jun; 102(6):1921-4. PubMed ID: 744059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of cations and guanyl nucleotides on agonist and antagonist binding to rat adrenal and uterine angiotensin II receptors.
    Capponi AM; Van KH; Vallotton MB
    Eur J Pharmacol; 1985 Aug; 114(3):325-33. PubMed ID: 2998811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classification of angiotensin receptors in rat isolated uterus, portal vein, and aorta with the novel competitive antagonist sarmesin.
    Scanlon MN; Moore GJ
    Pharmacology; 1988; 37(3):137-47. PubMed ID: 3227047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide antagonists of angiotensin-induced adrenal catecholamine release.
    Ackerly JA; Sarstedt CA; Peach MJ
    Eur J Pharmacol; 1977 Apr; 42(4):391-401. PubMed ID: 856615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Action of angiotensins I, II, and III on aldosterone production by isolated rat adrenal zona glomerulosa cells. importance of metabolism and conversion of peptides in vitro.
    Mendelsohn FA; Kachel CD
    Endocrinology; 1980 Jun; 106(6):1760-8. PubMed ID: 6154571
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.